Citation Impact
Citing Papers
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Structure of Human Angiotensinogen Gene
1989
Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A
1997 StandoutNatureNobel
Inflammation and metabolic disorders
2006 StandoutNature
Long-term uncoupling of chloride secretion from intracellular calcium levels by lns(3,4,5,6)P4
1994 StandoutNatureNobel
G-protein-coupled Receptor Kinase Specificity for β-Arrestin Recruitment to the β2-Adrenergic Receptor Revealed by Fluorescence Resonance Energy Transfer
2006 StandoutNobel
Expression of insulin regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients
1990
Fluorescent Labeling of Purified β2 Adrenergic Receptor
1995 StandoutNobel
Role of phosphorylation in desensitization of the β-adrenoceptor
1990 StandoutNobel
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
1997 StandoutNature
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
Comparative studies on species-specific reactivity between renin and angiotensinogen
1994
Regulation of glucose transporter messenger RNA in insulin-deficient states
1989 Nature
Gβγ Subunits Mediate Mitogen-activated Protein Kinase Activation by the Tyrosine Kinase Insulin-like Growth Factor 1 Receptor
1995 StandoutNobel
Epidermal Growth Factor (EGF) Receptor-dependent ERK Activation by G Protein-coupled Receptors
2001 StandoutNobel
Phosphorylation and Desensitization of the Human β1-Adrenergic Receptor
1995 StandoutNobel
Characterization of a membrane‐associated phosphotyrosyl protein phosphatase from the A431 human epidermoid carcinoma cell line
1989
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Adrenergic receptor signal transduction and regulation
1995 StandoutNobel
Phosphorylation of the Type 1A Angiotensin II Receptor by G Protein-coupled Receptor Kinases and Protein Kinase C
1996 StandoutNobel
Molecular mechanisms of membrane receptor desensitization
1993
Phosphorylation and Desensitization of Human Endothelin A and B Receptors
1997 StandoutNobel
Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation
1991
Continuous spectrophotometric assay of protein tyrosine phosphatase using phosphotyrosine
1992 StandoutNobel
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
G Protein-coupled Receptors
1998 StandoutNobel
Leptin and the regulation of body weight in mammals
1998 StandoutNature
Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.
1994
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes
1989
Protein Kinase A-mediated Phosphorylation of the β2-Adrenergic Receptor Regulates Its Coupling to Gs and Gi
2002 StandoutNobel
GTP‐binding protein‐activator sequences in the insulin receptor
1993
Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation
1994 StandoutNatureNobel
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.
1990 StandoutNobel
Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors.
1992 StandoutNobel
Evidence Against Altered Expression of GLUT1 or GLUT4 in Skeletal Muscle of Patients With Obesity or NIDDM
1990
Protein phosphotyrosine phosphatase purified from the particulate fraction of human placenta dephosphorylates insulin and growth-factor receptors
1988
CD45, an integral membrane protein tyrosine phosphatase. Characterization of enzyme activity.
1990 StandoutNobel
Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems.
1992 StandoutNobel
The Insulin-Sensitive Glucose Transporter
1992
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
Membrane-permeant Esters of Phosphatidylinositol 3,4,5-Trisphosphate
1998 StandoutNobel
Essential role of β-adrenergic receptor kinase 1 in cardiac development and function
1996 StandoutNobel
Agonist-induced conformational changes in the G-protein-coupling domain of the β 2 adrenergic receptor
2001 StandoutNobel
Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family.
1992 StandoutNobel
Effects of Leptin on Insulin Sensitivity in Normal Rats*
1997
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
The glucose transporter family: structure, function and tissue-specific expression
1993
A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.
1993 StandoutNobel
Divergent molecular mechanisms for insulin-resistant glucose transport in muscle and adipose cells in vivo.
1990
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Two distinct pathways for cAMP-mediated down-regulation of the β2-adrenergic receptor
1989 StandoutNobel
The substance P receptor, which couples to Gq/11, is a substrate of beta-adrenergic receptor kinase 1 and 2
1993 StandoutNobel
Antagonism of Catecholamine Receptor Signaling by Expression of Cytoplasmic Domains of the Receptors
1993 StandoutScienceNobel
Tyrosine Kinase Inhibition: An Approach to Drug Development
1995 Science
A cAMP response element in the beta 2-adrenergic receptor gene confers transcriptional autoregulation by cAMP.
1990 StandoutNobel
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
2009 StandoutNobel
A beta-adrenergic receptor kinase-like enzyme is involved in olfactory signal termination.
1993 StandoutNobel
cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family.
1989 StandoutNobel
Complete sequence of the bithorax complex of Drosophila.
1995 StandoutNobel
Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP.
1993 StandoutNobel
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
1996 StandoutScience
Structure and mechanism of the G protein-coupled receptor kinases.
1993 StandoutNobel
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
Works of H.V. Strout being referenced
A protein phosphotyrosine phosphatase distinct from alkaline phosphatase with activity against the insulin receptor
1988
Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells
1989
The Function but Not the Expression of Rat Liver Inhibitory Guanine Nucleotide Binding Protein Is Altered in Streptozotocin-Induced Diabetes
1991
Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting
1989 Nature
Pure human renin. Identification and characterization and of two major molecular weight forms.
1981
Synthetic segments of the mammalian βAR are preferentially recognized by cAMP-dependent protein kinase and protein kinase C
1987